KALA BIO (KALA) Stock Chart & Stock Price History → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free KALA Stock Alerts $6.18 -0.22 (-3.44%) (As of 05:44 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability KALA BIO Stock Price Performance5 Day Performance-6.22%1 Month Performance-22.46%3 Month Performance-13.32%6 Month Performance-14.99%Year-To-Date Performance-11.71%1 Year Performance-60.18% Receive KALA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for KALA BIO and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. KALA Stock Chart for Thursday, April, 25, 2024 KALA Chart by TradingView KALA BIO Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/24/2024$6.50$6.35-2.31%$6.51$6.351,101 shs$17.91 million04/23/2024$6.33$6.50+2.69%$6.68$6.225,284 shs$18.33 million04/22/2024$6.59$6.33-3.95%$6.47$6.1712,630 shs$17.85 million04/19/2024$6.77$6.33-6.50%$6.83$6.337,568 shs$17.85 million04/18/2024$6.84$6.77-1.02%$6.90$6.669,250 shs$19.09 million04/17/2024$6.89$6.84-0.73%$6.99$6.6514,754 shs$19.29 million Get the Latest News and Ratings for KALA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for KALA BIO and its competitors with MarketBeat's FREE daily newsletter. 04/16/2024$7.00$6.89-1.57%$7.19$6.8516,348 shs$19.43 million04/15/2024$7.20$7.00-2.78%$7.20$7.0023,989 shs$19.71 million04/12/2024$7.36$7.20-2.17%$7.30$7.2016,054 shs$20.30 million04/11/2024$7.35$7.36+0.14%$7.61$7.2018,704 shs$20.73 million04/10/2024$7.40$7.35-0.68%$7.49$7.2120,847 shs$20.70 million04/09/2024$7.62$7.40-2.89%$7.70$7.4018,332 shs$20.87 million04/08/2024$7.60$7.62+0.26%$7.80$7.565,618 shs$21.49 million04/05/2024$7.73$7.64-1.23%$7.97$7.6013,145 shs$21.53 million04/04/2024$7.83$7.73-1.28%$8.01$7.734,973 shs$21.80 million04/03/2024$7.99$7.83-2.00%$7.99$7.7221,515 shs$22.08 million04/02/2024$7.92$7.99+0.88%$8.12$7.8111,787 shs$21.49 million04/01/2024$7.97$7.92-0.63%$8.00$7.7814,287 shs$21.31 million03/29/2024$7.84$7.97+1.66%$8.00$7.819,909 shs$21.44 million03/28/2024$7.85$7.84-0.13%$7.99$7.789,908 shs$21.09 million03/27/2024$7.98$7.85-1.63%$8.00$7.708,552 shs$21.12 million03/26/2024$7.97$7.98+0.13%$8.00$7.6414,742 shs$21.47 million03/25/2024$7.99$7.97-0.25%$8.00$7.8722,972 shs$21.44 million03/22/2024$7.86$7.99+1.65%$8.00$7.888,259 shs$21.49 million03/21/2024$7.95$7.86-1.13%$8.00$7.6914,257 shs$21.14 million03/20/2024$7.72$7.95+2.98%$8.00$7.6820,790 shs$21.39 million03/19/2024$7.70$7.72+0.26%$8.00$7.5517,406 shs$20.77 million03/18/2024$7.53$7.70+2.26%$8.00$7.5127,142 shs$20.71 million03/15/2024$7.63$7.53-1.31%$7.79$7.5111,884 shs$20.26 million03/14/2024$7.65$7.63-0.26%$7.69$7.509,907 shs$20.53 million03/13/2024$7.57$7.65+1.06%$7.70$7.537,550 shs$20.58 million03/12/2024$7.82$7.57-3.20%$7.83$7.569,182 shs$20.36 million03/11/2024$7.50$7.82+4.27%$7.99$7.5018,336 shs$21.04 million03/08/2024$7.41$7.50+1.21%$7.70$7.3320,386 shs$20.18 million03/07/2024$7.49$7.41-1.07%$7.58$7.3017,913 shs$19.93 million03/06/2024$7.42$7.49+0.94%$7.55$7.309,092 shs$20.15 million03/05/2024$7.69$7.42-3.51%$7.55$7.318,471 shs$19.96 million03/04/2024$7.33$7.69+4.91%$7.80$7.3131,846 shs$20.69 million03/01/2024$7.18$7.33+2.09%$7.50$7.0531,576 shs$19.72 million02/29/2024$7.15$7.18+0.42%$7.30$7.0339,250 shs$19.31 millionBetter than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>>02/28/2024$7.15$7.15$7.34$7.119,072 shs$19.23 million02/27/2024$7.11$7.15+0.56%$7.22$7.0611,084 shs$19.23 million02/26/2024$7.06$7.11+0.71%$7.45$7.0230,323 shs$19.15 million02/23/2024$7.81$7.11-8.96%$7.76$7.0144,538 shs$19.13 million02/22/2024$7.14$7.81+9.38%$8.23$7.06171,484 shs$21.01 million02/21/2024$7.17$7.14-0.42%$7.14$6.832,774 shs$19.21 million02/20/2024$7.09$7.17+1.13%$7.17$6.796,819 shs$19.29 million02/19/2024$7.09$7.09$7.18$7.0012,300 shs$19.07 million02/16/2024$7.19$7.09-1.39%$7.18$7.0012,366 shs$19.07 million02/15/2024$6.87$7.19+4.66%$7.35$6.9225,357 shs$19.34 million02/14/2024$6.99$6.87-1.72%$7.18$6.7424,566 shs$18.48 million02/13/2024$7.18$6.99-2.65%$7.24$6.9125,320 shs$18.80 million02/12/2024$7.37$7.18-2.58%$7.35$7.179,959 shs$19.31 million02/09/2024$6.94$7.37+6.20%$7.39$6.9235,804 shs$19.83 million02/08/2024$6.93$6.94+0.14%$7.15$6.903,718 shs$18.67 million02/07/2024$7.01$6.93-1.14%$7.32$6.8553,614 shs$18.64 million02/06/2024$6.97$7.01+0.57%$7.01$6.717,900 shs$18.86 million02/05/2024$6.96$6.97+0.14%$7.10$6.6514,248 shs$18.75 million02/02/2024$6.88$6.96+1.16%$6.98$6.4349,010 shs$18.74 million02/01/2024$6.95$6.88-1.01%$7.04$6.8713,638 shs$18.51 million01/31/2024$7.04$6.95-1.28%$7.13$6.9244,124 shs$18.70 million01/30/2024$7.29$7.04-3.43%$7.23$6.9625,248 shs$18.94 million01/29/2024$7.12$7.29+2.39%$7.38$7.1213,639 shs$19.61 million01/26/2024$7.13$7.12-0.14%$7.30$7.1021,963 shs$19.15 million01/25/2024$7.17$7.13-0.56%$7.32$7.119,938 shs$19.18 million01/24/2024$7.19$7.17-0.28%$7.48$7.0239,925 shs$19.29 million Related Companies: ZIVO Bioscience Stock Chart Alaunos Therapeutics Stock Chart Lipocine Stock Chart PHAXIAM Therapeutics Stock Chart Bionomics Stock Chart Acasti Pharma Stock Chart LianBio Stock Chart Brainstorm Cell Therapeutics Stock Chart SAB Biotherapeutics Stock Chart BioLineRx Stock Chart Receive KALA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for KALA BIO and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KALA) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsJim Cramer’s “The Biggest Drug Ever”Behind the MarketsYour Money is Not SafeAmerican AlternativeThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KALA BIO, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.